<
Tracking Shijiazhuang Pharmaceutical Company Discontinued: Many companies apply for recovery production
Release time: 2016-11-24 & nbsp & nbsp & nbsp Source: Anonymous
  These two days,Shijiazhuang City, due to the treatment of haze to control the suspension of production limited in the industry, continues to ferment,Supervision plus code,Multi -pharmaceutical companies discontinue production。It is understood,Yiling Pharmaceutical (002603.SZ) and Shenwei Pharmaceuticals are preparing to stop production、Discontinued,Shi Si Pharmaceutical Group subsidiary discontinued production。
 
  Shijiazhuang is one of the important towns gathered by Chinese pharmaceutical companies。Stone Medicine Group、Shi Siyao Group、Shenwei Pharmaceutical、North China Pharmaceutical、Many listed pharmaceutical companies such as Yiling Pharmaceuticals are stationed My stake betting apphere,My stake betting appThere are still many small and medium -sized pharmaceutical companies。
 
  Monday,Stone Medicine Group、North China Pharmaceutical Double Stop trading,At 7 o'clock last night,Two companies announced that they will resume trading today。Stone medicine stocks after resumption of trading,Fall first and then rise,Close up nearly 2 percentage points。North China Pharmaceutical's stock performance has no stone medicine & ldquo; lucky & rdquo;,Fall 1.6 percentage points today。
 
  The earliest announcement of the discontinued North China Pharmaceutical this time from the parent company to the subsidiary,A total of 5 companies,In 2015, a total of more than 3 billion yuan in revenue。Northern China Pharmaceutical Title,Part of the business involved in the suspension of production may affect the current profit of 50 million yuan。Northern China Pharmaceutical Title,Main products have a certain amount of stocking,According to the preliminary budget at the end of the year to the end of the year,Preparation products are not affected。
 
  An announcement of another Hong Kong stock market pharmaceutical company Shi Four Medicine Group announced,Its subsidiaries in Shijiazhuang have been discontinued on November 19。This subsidiary mainly produces varicose infusion -related products,93%of the total income of the first half of this year in the first half of this year。
 
  It is characterized by traditional Chinese medicine preparations,Yesterday & ldquo; Divine Pharmaceuticals said that it was discontinued today。At about 2 pm this stake sports betting appafternoon,An insider of Shenwei stake sports betting appPharmaceutical revealed to reporters,Shenwei Pharmaceutical's discontinuation last night,& ldquo; due to the specialty of some crafts,From the 18th, it has gradually limited production,Government supervision intensity increases,Beginning to stop production,Basically discontinued last night。& rdquo;。According to the Securities Times also reported,Yiling Pharmaceutical is also preparing before production as required。
 
  In terms of pharmaceutical reserves,Generally speaking,Each family conveys the signal of relative & ldquo; optimism & ldquo;,Related preparation measures for production suspension,Before the end of January, it can completely ensure that the company's product market supply is not affected。In response to the securities Times about & ldquo; As for why the company's preparation is sufficiently & rdquo; time,Yiling Pharmaceutical Representation,It affects the impact of air pollution in early winter in advance,Planning has increased production volume since July 2016,Do a good job of inventory reserves for major products,At present, there are sufficient inventory of patent products and drug products。
 
  For drug reserves,Shenwei Pharmaceuticals told reporters,Its & ldquo; Pharmaceutical conventional inventory reserves for one to two months & rdquo;。Although the subsidiary of Shijiazhuang's subsidiary contributed to its revenue exceeded 90 %,Dani Four Medicine Group still gives a fairly optimistic estimate in the announcement: & ldquo; It is expected that the stake online sports bettinggovernment stake online sports bettingwill have a positive reply,Request for production expectations before the end of November 2016。& rdquo;,Press this expectation,With its inventory level,will not affect performance。Of course,Converse speculation,Or can be estimated that the inventory of Shi Si Pharmaceutical Group。
 
  For Shijiazhuang's & ldquo; stop production & ldquo;,The industry itself is quite micro -word,Represents the government's approach or lose wisdom。and on the other side,Enterprises are also negotiating and government negotiations & ldquo; game & rdquo;。Stone Medicine Group said,Apply to the government for continuing production,Shi Si Pharmaceutical Group has also made relevant applications to the Shijiazhuang government,It is required that the government is allowed to allow the approval to restore production。Near Shenwei Pharmaceuticals also told reporters,Shenwei Pharmaceutical submitted an application for production restriction to the government yesterday,Not yet received the government's reply。
 
  A local pharmaceutical company said,Government supervision intensity increases。
 
  Another,It is not ruled out that Shijiazhuang's pharmaceutical company & ldquo; stop production & rdquo; staged in other parts of Hebei。Tangshan issued a decree this month,From November 15, 2016 to March 15, 2017, strengthening air pollution treatment,Among them, the same mentioned & ldquo; volatile organic matter process & rdquo;。Tangshan City said,November 15, 2016 to December 31,The procedures of the process of discharge volatile organic matter in volatile organic matter governance My stake betting appmission stake online sports bettingto reduce pollutant emissions by 50%; from January 1, 2017,The process of not completing volatile organic matter governance tasks involved in emission volatile organic matter,All discontinued management。
 
  An investor in Tangshan revealed to reporters,Tangshan involved in pharmaceutical companies will discontinue production on the 23rd。For this,The reporter has not been confirmed。